Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Sep 6.

Published in final edited form as: Clin Invest Med. 2009 Apr 1;32(2):E95–102. doi: 10.25011/cim.v32i2.6026

TABLE 3.

Baseline values of the variables used in the regression model, for the three groups of patients

	No scarring	Dupuytren’s	Keloid	P
Number	1679	57	12
Age (yr)	56.94 (1.04)	66.11 (9.85)	50.00 (14.81)	<0.0001
Male %	53%	80.7%	58.3%	<0.0001
Diabetic %	8.9%	5.3%	16.7%	0.0001
Smoking Pack-yr	12.51 (18.08)	16.92 (20.03)	5.58 (7.39)	0.08
Total cholesterol (mmol/L)	5.16 (1.10)	4.99 (1.16)	4.82 (0.87)	0.31
Systolic blood pressure (mmHg)	139.74 (21.47)	139.30 (21.47)	149.08 (19.29)	0.32
Antihypertensive therapy %	56.8%	42.1%	66.7%	0.069
Lipid-lowering therapy	47.65	42.1%	66.7%	0.30
Carotid plaque area (cm²)	0.85 (1.04)	1.35 (1.51)	1.03 (1.03)	0.002

^*

Chi-square for percentages, ANOVA for continuous variables